The Effect of Progressive Relaxation Exercise on Anxiety and Quality of Life of Diabetic Patients
Launched by KAHRAMANMARAŞ İSTIKLAL UNIVERSITY · Oct 5, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific type of exercise called progressive relaxation can help reduce anxiety and improve the quality of life for people with diabetes. The researchers want to find out if this exercise can make a positive difference for diabetic patients. They will be comparing two groups: one group will practice the relaxation exercises, while the other group will not participate in the exercises.
To join the study, participants must be at least 18 years old and currently being treated for diabetes. They should be willing to take part voluntarily and have no physical conditions that prevent them from doing the exercises. The trial is currently recruiting participants, and those who join can expect to engage in relaxation exercises that may help them feel less anxious and improve their overall well-being. This is an exciting opportunity for diabetic patients looking to enhance their health and quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diabetic patients who will be treated in the Internal Medicine Service who want to participate in the study voluntarily.
- • Patients over the age of 18
- Exclusion Criteria:
- • Patients who do not want to participate in the study.
- • Patients who are unable to perform the progressive relaxation exercise (amputation, etc.).
- • Pregnant or breastfeeding patients
About Kahramanmaraş İstiklal University
Kahramanmaraş İstiklal University is a distinguished academic institution dedicated to advancing research and education in various fields, including healthcare and clinical sciences. As a clinical trial sponsor, the university emphasizes a commitment to rigorous scientific inquiry, ethical standards, and the dissemination of knowledge. By fostering collaborations with healthcare professionals and researchers, Kahramanmaraş İstiklal University aims to contribute to the development of innovative therapies and improve patient outcomes through meticulously designed and conducted clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erzurum, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported